SEOUL – As South Korea accelerates into a super-aged society, a silent and dangerous health crisis is escalating: polypharmacy. This is the long-term, concurrent use of ten or more different medications, a practice that now involves over 1.7 million patients, predominantly those aged 65 and above. Experts warn that this growing reliance on multiple medications carries a disproportionately high risk of adverse drug reactions, hospitalization, and death, exposing critical flaws in the nation's healthcare system.

The Alarming Rise in Medication Load 

Data from the National Health Insurance Service reveals a stark picture: the number of patients on ten or more long-term medications for chronic diseases like hypertension and diabetes has surged by 52.5% in just five years, hitting 1.71 million this year. This trajectory is not only steep but also places South Korea far ahead of its peers. The nation's polypharmacy rate (for those 75+ taking five or more drugs) sits at a staggering 65.4%, significantly outpacing the OECD average of 44.5%.

This is more than a matter of statistical anomaly; it is a serious health hazard. According to the Health Insurance Review and Assessment Service (HIRA), elderly patients engaging in long-term polypharmacy face a 2.57 times higher risk of death, nearly doubling their likelihood of emergency room visits and hospital admissions.

"It's a complex interaction," explains Dr. Jang Geon-yeong, a specialist in geriatric internal medicine at Asan Medical Center, Seoul. "While simply taking more pills doesn't immediately cause death, the risk of consequences like falls, delirium, and severe medication errors increases dramatically." He also highlighted the danger of 'prescribing cascade,' a vicious cycle where a drug’s side effect—such as elevated blood pressure from long-term anti-inflammatory painkillers—is misdiagnosed as a new condition, leading to the prescription of yet another drug, like an antihypertensive, thereby compounding the problem.

Systemic Flaws Drive Drug Duplication 

Experts point to two main culprits behind this epidemic: demographic shift and systemic inefficiency.

First, the aggressive, multi-drug approach to managing multiple chronic conditions in an aging population is a global trend, but South Korea's highly fragmented healthcare system accelerates the problem.

"Patients often move between multiple hospitals and specialized departments—a cardiologist for hypertension, an endocrinologist for diabetes, a nephrologist for kidney issues—and there is no central mechanism for oversight," says Professor Kim Sun-wook of the Seoul National University Bundang Hospitalist Center. This 'siloed' approach inevitably results in overlapping and potentially dangerous prescriptions. Pharmacist Han Seul-gi from Asan Medical Center echoed this, criticizing the lack of a unified manager, such as a primary care physician or a designated pharmacist, to integrate and reconcile a patient's entire medication profile.

The Path to Safer Drug Management 

The consensus among healthcare professionals is clear: the focus must shift from simply medicating symptoms to ensuring patients take the correct and necessary drugs. The issue is often complicated by elderly patients themselves, who frequently misunderstand or are unaware of why they are taking certain medications.

A crucial, but currently underutilized, tool is HIRA's "My Medications at a Glance" service, designed to let patients and healthcare providers review their prescription history. Unfortunately, its effectiveness is hampered by bureaucracy.

"The current authentication process for elderly patients to verify their prescription history is too complex, often taking over twenty minutes," Pharmacist Han noted. "This makes it impractical for the fast-paced reality of clinical practice."

To effectively curb the risks of polypharmacy, a government-level systemic overhaul is imperative. Recommendations include:

Simplifying digital access to patient medication records, allowing immediate review by doctors and pharmacists with patient consent.
Introducing a dedicated drug review item during all regular health checkups.
Encouraging family involvement, particularly during times like holidays, to review and consolidate their elderly relatives' medication lists.
Until these systemic changes are implemented, the silent epidemic of polypharmacy will continue to pose a significant and unnecessary threat to the health and safety of South Korea’s burgeoning elderly population. The challenge is not just to treat disease, but to manage treatment itself.

[Copyright (c) Global Economic Times. All Rights Reserved.]